This report from Life Science Intelligence provides the latest market data for the Global Diagnostic Electrophysiology Devices Market. Information covered by this report includes:
· unit volumes & pricing forecast from 2019-2024
· analyses of the leading companies, and
· global market share analysis.
The global market for diagnostic electrophysiology devices is expected to reach an estimated $831.9 million in 2020 and is projected to increase at a CAGR (2020-2024) of 10.1%. This report covers catheter technologies for diagnostic electrophysiology procedures.
This report covers the impact of COVID-19 on the diagnostic electrophysiology devices market, including a recent forecast from 2020 to 2024. COVID-19 has also impacted leading competitors, such as Johnson & Johnson, Boston Scientific, Abbott, Medtronic, and others. The report provides insights into trends, drivers, and limiters of the diagnostic electrophysiology devices market, as well as highlights potential opportunities.
Diagnostic electrophysiology procedures were negatively impacted by the COVID-19 pandemic. These types of procedures are considered to be elective and thus were likely to be canceled or postponed. Procedure volumes are anticipated to rebound to pre-COVID-19 levels in 2021.
Johnson & Johnson, Boston Scientific, and Abbott dominate the diagnostic electrophysiology devices market with a combined market share of 85%.
The diagnostic electrophysiology devices market is seeing strong growth as cardiac ablation is being accepted as a competitive alternative to the pharmacological management of atrial fibrillation. Worldwide, atrial fibrillation affects approximately 37 million people.